Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal ⊕
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Organon
since
auto-detected in 2 stories
44 days ago
To fuel its global ambitions, Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion.
7 months ago
Stocks making the biggest moves midday: Qualcomm, Fermi, Dyne Therapeutics, Organon, Snowflake and more ○
These are some of the stocks posting the largest moves midday.
page 1 of 1